Being overweight or obese is associated with harboring a gut microbial community not capable of metabolizing the soy isoflavone daidzein to O-desmethylangolensin in peri- and post-menopausal women

Maturitas

Volumn 99, Issue , 2017, Pages 37-42

  Miller, Lindsey M ^a   Lampe, Johanna W ^b,d   Newton, Katherine M ^c,d   Gundersen, Gabrielle ^c   Fuller, Sharon ^c   Reed, Susan D ^b,c,d,e   Frankenfeld, Cara L ^a  

^a GEORGE MASON UNIVERSITY   (United States)

^b USA   (United States)

^c GROUP HEALTH RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Body mass index; Equol; Isoflavone soy intake; O desmethylangolensin; Obesity

Indexed keywords

DAIDZEIN; ISOFLAVONE DERIVATIVE; EQUOL; O-DESMETHYLANGOLENSIN;

ADULT; ARTICLE; BODY MASS; CHINESE; CLIMACTERIUM; CROSS-SECTIONAL STUDY; ETHNICITY; FEMALE; HUMAN; INTESTINE FLORA; KIDNEY CONCENTRATING CAPACITY; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; MICROBIAL COMMUNITY; OBESITY; PHENOTYPE; POSTMENOPAUSE; RACE; SOY FOOD; UNITED STATES; URINALYSIS; BIOSYNTHESIS; ETHNIC GROUP; METABOLISM; MICROBIOLOGY; MIDDLE AGED; ODDS RATIO; OVERWEIGHT; PHYSIOLOGY; URINE;

ADULT; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; EQUOL; ETHNIC GROUPS; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; ISOFLAVONES; MIDDLE AGED; OBESITY; ODDS RATIO; OVERWEIGHT; PERIMENOPAUSE; POSTMENOPAUSE;

EID: 85013763608     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2017.02.006     Document Type: Article

References (44)

1. [1] Ogden, C.L., Carroll, M.D., Curtin, L.R., McDowell, M.A., Tabak, C.J., Flegal, K.M., Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295:13 (2006), 1549–1555.
2. [2] Al-Safi, Z.A., Polotsky, A.J., Obesity and menopause, Best practice & research. Clin. Obstet. Gynaecol. 29:4 (2015), 548–553.
3. [3] Gibson, C.J., Thurston, R.C., El Khoudary, S.R., Sutton-Tyrrell, K., Matthews, K.A., Body mass index following natural menopause and hysterectomy with and without bilateral oophorectomy. Int. J. Obes. (Lond.) 37:6 (2013), 809–813.
4. [4] Rillamas-Sun, E., LaCroix, A.Z., Waring, M.E., Kroenke, C.H., LaMonte, M.J., Vitolins, M.Z., Seguin, R., Bell, C.L., Gass, M., Manini, T.M., Masaki, K.H., Wallace, R.B., Obesity and late-age survival without major disease or disability in older women. JAMA Intern. Med. 174:1 (2014), 98–106.
5. [5] Oparil, S., Women and hypertension: what did we learn from the Women's Health Initiative?. Cardiol. Rev. 14:6 (2006), 267–275.
6. [6] Rexrode, K.M., Emerging risk factors in women. Stroke 41:10 Suppl (2010), S9–11.
7. [7] Vincent, H.K., Vincent, K.R., Lamb, K.M., Obesity and mobility disability in the older adult. Obes. Rev. 11:8 (2010), 568–579.
8. [8] Tennyson, C.A., Friedman, G., Microecology, obesity, and probiotics. Curr. Opin. Endocrinol. Diabetes Obes. 15:5 (2008), 422–427.
9. [9] Hullar, M.A., Lampe, J.W., The gut microbiome and obesity. Nestle Nutr. Workshop Ser. 73 (2012), 67–79.
10. [10] Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R., Fernandes, G.R., Tap, J., Bruls, T., Batto, J.M., Bertalan, M., Borruel, N., Casellas, F., Fernandez, L., Gautier, L., Hansen, T., Hattori, M., Hayashi, T., Kleerebezem, M., Kurokawa, K., Leclerc, M., Levenez, F., Manichanh, C., Nielsen, H.B., Nielsen, T., Pons, N., Poulain, J., Qin, J., Sicheritz-Ponten, T., Tims, S., Torrents, D., Ugarte, E., Zoetendal, E.G., Wang, J., Guarner, F., Pedersen, O., de Vos, W.M., Brunak, S., Dore, J., Antolin, M., Artiguenave, F., Blottiere, H.M., Almeida, M., Brechot, C., Cara, C., Chervaux, C., Cultrone, A., Delorme, C., Denariaz, G., Dervyn, R., Foerstner, K.U., Friss, C., van de Guchte, M., Guedon, E., Haimet, F., Huber, W., van Hylckama-Vlieg, J., Jamet, A., Juste, C., Kaci, G., Knol, J., Lakhdari, O., Layec, S., Le Roux, K., Maguin, E., Merieux, A., Melo Minardi, R., M'Rini, C., Muller, J., Oozeer, R., Parkhill, J., Renault, P., Rescigno, M., Sanchez, N., Sunagawa, S., Torrejon, A., Turner, K., Vandemeulebrouck, G., Varela, E., Winogradsky, Y., Zeller, G., Weissenbach, J., Ehrlich, S.D., Bork, P., Enterotypes of the human gut microbiome. Nature 473:7346 (2011), 174–180.
11. [11] Turnbaugh, P.J., Quince, C., Faith, J.J., McHardy, A.C., Yatsunenko, T., Niazi, F., Affourtit, J., Egholm, M., Henrissat, B., Knight, R., Gordon, J.I., Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc. Natl. Acad. Sci. U. S. A. 107:16 (2010), 7503–7508.
12. [12] Costello, E.K., Lauber, C.L., Hamady, M., Fierer, N., Gordon, J.I., Knight, R., Bacterial community variation in human body habitats across space and time. Science 326:5960 (2009), 1694–1697.
13. [13] Lourdes, M., Cruz, A., Wong, W.W., Mimouni, F., Hachey, D.L., Setchell, K.D.R., Klein, P.D., Tsang, R.C., Effects of infant nutrition on cholesterol synthesis rates. Pediatr. Res. 35:2 (1994), 135–140.
14. [14] Frankenfeld, C.L., Atkinson, C., Thomas, W.K., Gonzalez, A., Jokela, T., Wahala, K., Schwartz, S.M., Li, S.S., Lampe, J.W., High concordance of daidzein-metabolizing phenotypes in individuals measured 1–3 years apart. Br. J. Nutr. 94:6 (2005), 873–876.
15. [15] Egert, M., de Graaf, A.A., Smidt, H., de Vos, W.M., Venema, K., Beyond diversity: functional microbiomics of the human colon. Trends Microbiol. 14:2 (2006), 86–91.
16. [16] Atkinson, C., Frankenfeld, C.L., Lampe, J.W., Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp. Biol. Med. (Maywood) 230:3 (2005), 155–170.
17. [17] Frankenfeld, C.L., O-Desmethylangolensin: the importance of equol's lesser known cousin to health human. Adv. Nutr. 2 (2011), 317–324.
18. [18] Liu, Z.M., Ho, S.C., Chen, Y.M., Liu, J., Woo, J., Cardiovascular risks in relation to daidzein metabolizing phenotypes among chinese postmenopausal women. PLoS One, 9(2), 2014, e87861.
19. [19] Atkinson, C., Newton, K.M., Bowles, E.J., Yong, M., Lampe, J.W., Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States. Am. J. Clin. Nutr. 87:3 (2008), 679–687.
20. [20] Frankenfeld, C.L., Atkinson, C., Thomas, W.K., Goode, E.L., Gonzalez, A., Jokela, T., Wähälä, K., Schwartz, S.M., Li, S.S., Lampe, J.W., Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes. Exp. Biol. Med. (Maywood) 229:9 (2004), 902–913.
21. [21] Frankenfeld, C.L., McTiernan, A., Tworoger, S.S., Atkinson, C., Thomas, W.K., Stanczyk, F.Z., Marcovina, S.M., Weigle, D.S., Weiss, N.S., Holt, V.L., Schwartz, S.M., Lampe, J.W., Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes. J. Steroid Biochem. Mol. Biol. 88:4–5 (2004), 399–408.
22. [22] Frankenfeld, C.L., Atkinson, C., Wahala, K., Lampe, J.W., Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein. Eur. J. Clin. Nutr. 68:4 (2014), 526–530.
23. [23] Newton, K.M., Reed, S.D., Uchiyama, S., Qu, C., Ueno, T., Iwashita, S., Gunderson, G., Fuller, S., Lampe, J.W., A cross-sectional study of equol producer status and self-reported vasomotor symptoms. Menopause 22:5 (2015), 489–495.
24. [24] Frankenfeld, C.L., Patterson, R.E., Kalhorn, T.F., Skor, H.E., Howald, W.N., Lampe, J.W., Validation of a soy food frequency questionnaire with plasma concentrations of isoflavones in US adults. J. Am. Diet. Assoc. 102:10 (2002), 1407–1413.
25. [25] Frankenfeld, C.L., Patterson, R.E., Horner, N.K., Neuhouser, M.L., Skor, H.E., Kalhorn, T.F., Howald, W.N., Lampe, J.W., Validation of a soy food-frequency questionnaire and evaluation of correlates of plasma isoflavone concentrations in postmenopausal women. Am. J. Clin. Nutr. 77:3 (2003), 674–680.
26. [26] World Health Organization (WHO), Obesity and overweight. , May, 2012 (Accessed December 17 2012).
27. [27] Frankenfeld, C.L., Cardiometabolic risk and gut microbial phytoestrogen metabolite phenotypes. Mol. Nutr. Food Res., 61(1), 2017.
28. [28] Atkinson, C., Newton, K.M., Stanczyk, F.Z., Westerlind, K.C., Li, L., Lampe, J.W., Daidzein-metabolizing phenotypes in relation to serum hormones and sex hormone binding globulin, and urinary estrogen metabolites in premenopausal women in the United States. Cancer Causes Control 19:10 (2008), 1085–1093.
29. [29] Atkinson, C., Newton, K.M., Yong, M., Stanczyk, F.Z., Westerlind, K.C., Li, L., Lampe, J.W., Daidzein-metabolizing phenotypes in relation to bone density and body composition among premenopausal women in the United States. Metabolism 61:12 (2012), 1678–1682.
30. [30] Li, M., Li, H., Zhang, C., Wang, X.L., Chen, B.H., Hao, Q.H., Wang, S.Y., Enhanced biosynthesis of O-desmethylangolensin from daidzein by a novel oxygen-tolerant cock intestinal bacterium in the presence of atmospheric oxygen. J. Appl. Microbiol. 118:3 (2015), 619–628.
31. [31] Schoefer, L., Mohan, R., Braune, A., Birringer, M., Blaut, M., Anaerobic C-ring cleavage of genistein and daidzein by Eubacterium ramulus. FEMS Microbiol. Lett. 208:2 (2002), 197–202.
32. [32] Hur, H.G., Beger, R.D., Heinze, T.M., Lay, J.O. Jr., Freeman, J.P., Dore, J., Rafii, F., Isolation of an anaerobic intestinal bacterium capable of cleaving the C-ring of the isoflavonoid daidzein. Arch. Microbiol. 178 (2002), 8–12.
33. [33] Shang, H., Sun, J., Chen, Y.Q., Clostridium butyricum CGMCC0313.1 modulates lipid profile, insulin resistance and colon homeostasis in obese mice. PLoS One, 11(4), 2016, e0154373.
34. [34] Woting, A., Pfeiffer, N., Loh, G., Klaus, S., Blaut, M., Clostridium ramosum promotes high-fat diet-induced obesity in gnotobiotic mouse models. MBio 5:5 (2014), e01530–14.
35. [35] Setchell, K.D., Brown, N.M., Summer, S., King, E.C., Heubi, J.E., Cole, S., Guy, T., Hokin, B., Dietary factors influence production of the soy isoflavone metabolite s-(−)equol in healthy adults. J. Nutr. 143:12 (2013), 1950–1958.
36. [36] Franke, A.A., Lai, J.F., Halm, B.M., Pagano, I., Kono, N., Mack, W.J., Hodis, H.N., Equol production changes over time in postmenopausal women. J. Nutr. Biochem. 23:6 (2012), 573–579.
37. [37] Franke, A.A., Lai, J.F., Pagano, I., Morimoto, Y., Maskarinec, G., Equol production changes over time in pre-menopausal women. Br. J. Nutr. 107:8 (2012), 1201–1206.
38. [38] Brown, N.M., Galandi, S.L., Summer, S.S., Zhao, X., Heubi, J.E., King, E.C., Setchell, K.D., S-(−)equol production is developmentally regulated and related to early diet composition. Nutr. Res. (New York, N.Y.) 34:5 (2014), 401–409.
39. [39] Mueller, S., Saunier, K., Hanisch, C., Norin, E., Alm, L., Midtvedt, T., Cresci, A., Silvi, S., Orpianesi, C., Verdenelli, M.C., Clavel, T., Koebnick, C., Zunft, H.J., Dore, J., Blaut, M., Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl. Environ. Microbiol. 72:2 (2006), 1027–1033.
40. [40] Zhao, L., Xu, W., Ibrahim, S.A., Jin, J., Feng, J., Jiang, J., Meng, J., Ren, F., Effects of age and region on fecal microflora in elderly subjects living in Bama, Guangxi, China. Curr. Microbiol. 62:1 (2011), 64–70.
41. [41] De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J.B., Massart, S., Collini, S., Pieraccini, G., Lionetti, P., Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. U. S. A. 107:33 (2010), 14691–14696.
42. [42] Yatsunenko, T., Rey, F.E., Manary, M.J., Trehan, I., Dominguez-Bello, M.G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R.N., Anokhin, A.P., Heath, A.C., Warner, B., Reeder, J., Kuczynski, J., Caporaso, J.G., Lozupone, C.A., Lauber, C., Clemente, J.C., Knights, D., Knight, R., Gordon, J.I., Human gut microbiome viewed across age and geography. Nature 486:7402 (2012), 222–227.
43. [43] Lin, A., Bik, E.M., Costello, E.K., Dethlefsen, L., Haque, R., Relman, D.A., Singh, U., Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States. PLoS One, 8(1), 2013, e53838.
44. [44] Tyakht, A.V., Kostryukova, E.S., Popenko, A.S., Belenikin, M.S., Pavlenko, A.V., Larin, A.K., Karpova, I.Y., Selezneva, O.V., Semashko, T.A., Ospanova, E.A., Babenko, V.V., Maev, I.V., Cheremushkin, S.V., Kucheryavyy, Y.A., Shcherbakov, P.L., Grinevich, V.B., Efimov, O.I., Sas, E.I., Abdulkhakov, R.A., Abdulkhakov, S.R., Lyalyukova, E.A., Livzan, M.A., Vlassov, V.V., Sagdeev, R.Z., Tsukanov, V.V., Osipenko, M.F., Kozlova, I.V., Tkachev, A.V., Sergienko, V.I., Alexeev, D.G., Govorun, V.M., Human gut microbiota community structures in urban and rural populations in Russia. Nat. Commun., 4, 2013, 2469.